Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TECELRA safely and effectively. See full prescribing information for TECELRA. TECELRA® (afamitresgene autoleucel) suspension, for intravenous infusion Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-other
TECELRA is indicated for the treatment of adults and pediatric patients 12 years of age and older with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive and whose tumor expresses the MAGE-A4 antigen as determined by FDA-approved or cleared companion diagnostic devices.
- generic_name
- afamitresgene autoleucel
- product_names
- afamitresgene autoleucel
- ndc
- 83205-0001, 83205-0001-2
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en